Vaxart, Inc. Operating Income Loss

• Vaxart, Inc. showed an increase of +127.3% in Operating Income Loss from 2024 to 2025.
• This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: -$3.49 million | Q3 2010: $3.28 million | Q1 2011: $1.87 million | Q2 2011: -$4.69 million | Q3 2011: -$4.94 million | Q4 2011: -$8.42 million | Q1 2012: -$2.63 million | Q2 2012: -$2.88 million | Q3 2012: -$7.80 million | Q4 2012: -$7.80 million | Q1 2013: $0.00 | Q3 2013: -$4.10 million | Q4 2013: -$100.0 thousand | Q1 2014: $3.20 million | Q3 2014: -$7.00 million | Q4 2014: $6.40 million | Q1 2015: $1.10 million | Q3 2015: -$6.70 million | Q4 2015: -$6.50 million | Q1 2016: -$5.20 million | Q3 2016: -$9.60 million | Q4 2016: -$8.60 million | Q1 2017: -$2.25 million | Q2 2017: -$3.12 million | Q3 2017: -$1.96 million | Q4 2017: -$2.90 million | Q1 2018: -$3.92 million | Q2 2018: -$7.78 million | Q3 2018: -$5.88 million | Q1 2019: -$448.0 thousand | Q2 2019: -$5.00 million | Q3 2019: -$4.71 million | Q1 2020: -$694.0 thousand | Q2 2020: -$8.53 million | Q3 2020: -$7.59 million | Q1 2021: -$15.51 million | Q2 2021: -$15.78 million | Q3 2021: -$17.25 million | Q1 2022: -$24.78 million | Q2 2022: -$29.25 million | Q3 2022: -$29.43 million | Q1 2023: -$25.57 million | Q2 2023: -$23.05 million | Q3 2023: -$17.82 million | Q1 2024: -$24.07 million | Q2 2024: -$16.26 million | Q3 2024: -$14.48 million | Q1 2025: -$14.94 million | Q2 2025: -$14.60 million | Q3 2025: -$7.81 million.
• Over the full 19 years of available data (2009 to 2025), Vaxart, Inc.'s Operating Income Loss has grown by 200.5%.
• Historical annual values: Fiscal year 2025: $18.07 million | Fiscal year 2024: -$66.29 million | Fiscal year 2023: -$83.35 million | Fiscal year 2022: -$114.59 million | Fiscal year 2021: -$72.75 million | Fiscal year 2020: -$30.17 million | Fiscal year 2019: -$15.79 million | Fiscal year 2018: -$21.76 million | Fiscal year 2017: -$10.02 million | Fiscal year 2017: -$27.50 million | Fiscal year 2016: -$25.20 million | Fiscal year 2015: -$19.50 million | Fiscal year 2014: -$11.50 million | Fiscal year 2013: -$22.10 million | Fiscal year 2012: -$22.90 million | Fiscal year 2011: -$9.76 million | Fiscal year 2011: -$30.50 million | Fiscal year 2010: -$1.20 million | Fiscal year 2009: -$17.98 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026